Andreas Ujdud Wali MD FACC, FSCAI
Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Director, Structural Heart Disease
Join to view full profile
20 Capital DrHarrisburg, PA 17110
Phone+1 717-724-6450
Fax+1 717-724-6451
Dr. Wali is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Morningside/BronxCareFellowship, Cardiovascular Disease, 1995 - 1998- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1992 - 1995
University of IbadanClass of 1987
Certifications & Licensure
NY State Medical License 1995 - 2028
PA State Medical License 1999 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification GEMMS ONE, GEMMS, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- 3 citationsChocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study.Tanja Böhme, Thomas Zeller, Mehdi H Shishehbor, Martin Werner, Marianne Brodmann
Journal of Endovascular Therapy. 2025-04-01 - 19 citationsRandomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).Mehdi H Shishehbor, Thomas Zeller, Martin Werner, Marianne Brodmann, Helen Parise
Circulation. 2022-05-31 - 26 citationsThe determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for hepa...Michael S. Lee, Andreas U. Wali, Venu Menon, Scott D. Berkowitz, Trevor D. Thompson
Journal of Thrombosis and Thrombolysis. 2002-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
